Off-the-Shelf iPSC CAR-T Data in Systemic Sclerosis

Summary Fate Therapeutics announced that preliminary clinical data from the systemic sclerosis arm of its Phase 1 FT819 basket trial will be presented at ISSCR 2026. The first four treated systemic sclerosis patients showed clinical response signals, including rCRISS25 or higher and meaningful skin-score improvement…